Haemonetics HAE Income Statement
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| $1.33B+1.2% | $1.32B-0.7% | $1.33B-1.4% | $1.35B-1.1% | $1.36B-0.9% | ||
| $546.44M+2.0% | $535.85M-3.3% | $554.27M-4.4% | $579.77M-5.2% | $611.87M-4.6% | ||
| $787.59M+0.7% | $782.42M+1.1% | $773.59M+1.0% | $766.28M+2.3% | $748.96M+2.3% | ||
| 59%-0.3pp | 59.4%+1.1pp | 58.3%+1.3pp | 56.9%+1.9pp | 55%+1.8pp | ||
| $59.77M-6.1% | $63.63M-2.5% | $65.27M+1.1% | $64.53M+2.9% | $62.72M+4.1% | ||
| $442.42M+1.3% | $436.62M+0.6% | $433.93M-1.2% | $439.26M+0.6% | $436.79M+1.4% | ||
| $111.72M-0.8% | $112.61M-1.4% | $114.25M-0.8% | $115.21M-0.3% | $115.59M+0.5% | ||
| $630.85M+18.7% | $531.33M+0.1% | $530.86M+0.1% | $530.35M+0.6% | $527.14M-4.4% | ||
| —— | $251.09M+3.4% | $242.73M+2.9% | $235.93M+6.4% | $221.82M+22.9% | ||
| -$28.7M-20.0% | -$23.93M+6.6% | -$25.62M-0.8% | -$25.41M-161% | -$9.75M+37.8% | ||
| —— | $227.17M+4.6% | $217.11M+3.1% | $210.53M-0.7% | $212.07M+28.7% | ||
| —— | $51.73M+5.7% | $48.92M+3.7% | $47.19M+6.3% | $44.39M+28.0% | ||
| —— | $175.44M+4.3% | $168.19M+3.0% | $163.34M-2.6% | $167.68M+28.9% | ||
| —— | $3.63+6.1% | $3.42+4.6% | $3.27-1.2% | $3.31+30.3% | ||
| —— | $3.65+6.1% | $3.44+4.6% | $3.29-1.2% | $3.33+30.1% | ||
| 190.4M-1.7% | 193.7M-1.9% | 197.4M-1.8% | 201M-1.6% | 204.2M-0.3% | ||
| 189.7M-1.6% | 192.8M-1.8% | 196.3M-1.7% | 199.6M-1.4% | 202.5M-0.2% | ||
| $44M-1.8% | $44.8M-2.8% | $46.1M-2.3% | $47.18M-2.2% | $48.26M+1.8% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $86.55M+32.1% | $65.51M+47.3% | $44.47M+89.8% | $23.43M+880% | $2.39M-45.6% | ||
| —— | —— | —— | —— | —— | ||
| $14.88M+184% | -$17.69M-264% | -$4.86M-91.2% | -$2.54M+63.4% | -$6.96M— | ||
| -$47.36M-22.9% | -$38.54M-423% | -$7.36M-129% | $25.18M-61.1% | $64.7M-22.7% | ||
| $35.03M— | —— | —— | —— | —— | ||
| -$180.49M— | —— | —— | —— | —— | ||
| -$179.55M— | —— | —— | —— | —— | ||
| $293.22M-13.5% | $338.84M+17.2% | $289.04M+27.6% | $226.54M+24.7% | $181.73M+40.6% | ||
| -$28.7M-20.0% | -$23.93M+6.6% | -$25.62M-0.8% | -$25.41M-161% | -$9.75M+37.8% | ||
| $10.73M+62.1% | $6.62M-18.7% | $8.13M-17.6% | $9.87M-1.1% | $9.98M-28.7% | ||
| —— | —— | —— | —— | —— | ||
| $0— | —— | —— | —— | —— | ||
| $32.78M+6.6% | $30.76M-6.7% | $32.96M-11.8% | $37.38M-4.8% | $39.28M+29.5% | ||
| -$102K+12.1% | -$116K+53.8% | -$251K-12.6% | -$223K+10.4% | -$249K+24.5% | ||
| $1.38M-58.3% | $3.3M+5.8% | $3.12M-14.5% | $3.65M-84.3% | $23.25M+8.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | $6.25M0.0% | $6.25M+33.3% | $4.69M0.0% | $4.69M-29.2% | ||
| —— | —— | —— | —— | —— | ||
| $33.83M+6.9% | $31.64M-1.3% | $32.05M+2.3% | $31.32M+5.7% | $29.64M-1.6% | ||
| —— | $251.09M+3.4% | $242.73M+2.9% | $235.93M+6.4% | $221.82M+22.9% | ||
| —— | $363.7M+1.9% | $356.97M+1.7% | $351.14M+4.1% | $337.4M+14.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.